Industry News - Tag: Medsafe

You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.

Regulatory in brief | Norway, US, New Zealand

29 March 2021

The Norwegian Medicines Agency (NoMA) is postponing some non-prescription medicines work due to the COVID-19 pandemic, the US has a new secretary of the Department of Health & Human Services (HHS), and New Zealand’s Medsafe has announced changes affecting medicines containing paracetamol.

Read the full story

New Zealand sticks by pholcodine recommendation
Premium

16 December 2020

New Zealand’s Medicines Classification Committee (MCC) is sticking by its recommendation that pholcodine should be reverse-switched from pharmacy-only to pharmacist-only status. The MCC has also made recommendations on fexofenadine, flurbiprofen and ibuprofen.

Read the full story

Regulatory in brief | opioids, pholcodine, Arthrem

23 September 2020

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has introduced stronger warnings for prescribed and OTC medicines containing opioids, while New Zealand’s Medsafe is to reconsider a recent recommendation for pholcodine and has reached a settlement over Arthrem.

Read the full story